Factors predictive for response of follicular and mantle cell lymphoma to rituximab Michael Pfreundschuh 1 July 2006 Impact Factor 0 Number 13 Download pdf article A recent analysis of prognostic factors may help identify which follicular and mantle cell lymphoma patients should be excluded from trials of single-agent rituximab therapy. Download full article follicular and mantle cell lymphomarituximab
Impact Factor Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma? Impact Factor 1 November 2007 0
